LYNETTE ROSSBACK: Open Payments
NPI 1720487598 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 10 payments from 7 companies in 2025. Trend: 2023 $102 · 2024 $184 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $70 |
| ABBVIE INC. | 2 | $43 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $32 |
| Amgen Inc. | 1 | $28 |
| Alkermes, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Abbott Laboratories | 1 | $20 |
Products named: SHINGRIX, VRAYLAR, JOURNAVX, KRYSTEXXA, VIVITROL, ROTATEQ, BEXSERO, FREESTYLE LIBRE 3.
Industry payments across NV — which companies pay providers there.
